Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
PharmacoEconomics
Metadata
Title
Impact of Medicaid Preferred Drug Lists on Therapeutic Adherence
Authors
David B. Ridley
Kirsten J. Axelsen
Publication date
01-12-2006
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue Special Issue 3/2006
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200624003-00006

Other articles of this Special Issue 3/2006

PharmacoEconomics 3/2006 Go to the issue

Original Research

The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003

Original Research

Per-patient-per-month Drug Costs in Medicare Part D Protected Classes

Original Research

Which Physicians are Affected Most by Medicaid Preferred Drug Lists for Statins and Antihypertensives?

Original Research

Preferred Drug Lists and Medicaid Prescriptions

Original Research

Effects of Medicaid Access Restrictions on Statin Utilisation for Patients Treated by Physicians Practising in Poor and Minority Neighbourhoods

Introduction

Medicaid Preferred Drug Lists: Cost Containment and Side Effects